U.S. Markets open in 1 min.

AngioDynamics, Inc. (ANGO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.82+0.16 (+1.02%)
At close: 4:00PM EDT

15.82 0.00 (0.00%)
Pre-Market: 8:29AM EDT

People also watch
ATRCMMSICUTRELGXABMD

AngioDynamics, Inc.

14 Plaza Drive
Latham, NY 12110
United States
518-795-1400
http://www.angiodynamics.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees1,300

Key Executives

NameTitlePayExercisedAge
Mr. James C. ClemmerChief Exec. Officer, Pres and Director86.56kN/A53
Mr. Stephen A. TrowbridgeSr. VP, Gen. Counsel and Assistant Sec.394.06k3.13k43
Mr. Michael C. GreinerChief Financial Officer and Exec. VPN/AN/AN/A
Mrs. Barbara kucharczykSr. VP of Global OperationsN/AN/A44
Mr. Ben DavisSr. VP of Bus. Devel.N/AN/A53
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. AngioDynamics, Inc. sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Corporate Governance

AngioDynamics, Inc.’s ISS Governance QualityScore as of May 1, 2017 is 3. The pillar scores are Audit: 2; Board: 2; Shareholder Rights: 6; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.